Aging and aerobic fitness affect the contribution of noradrenergic sympathetic nerves to the rapid cutaneous vasodilator response to local heating by Tew, G. A. et al.
Aging and aerobic fitness affect the contribution of noradrenergic 1 
sympathetic nerves to the rapid cutaneous vasodilator response to 2 
local heating 3 
 4 
GARRY A. TEW1, JOHN M. SAXTON2, MARKOS KLONIZAKIS1, JAMES MOSS1, 5 
ALAN D. RUDDOCK1, GARY J. HODGES3 6 
 7 
1Centre for Sport and Exercise Science, Sheffield Hallam University, UK 8 
2School of Allied Health Professions, University of East Anglia, UK 9 
3Department of Kinesiology, The University of Alabama, USA 10 
 11 
Running head: Sympathetic nerves, thermal hyperemia and aging 12 
 13 
KEYWORDS: Skin blood flow, age, heat 14 
 15 
Word Count: 5,327 16 
 17 
Corresponding author: 18 
Gary J. Hodges, PhD 19 
Department of Kinesiology 20 
The University of Alabama 21 
112 Moore Hall 22 
Tuscaloosa, AL 35487, USA 23 
Phone: (205) 348-2151 24 
Fax: (205) 348-0867 25 
Email: ghodges1@bamaed.ua.edu 26 
 27 
 28 
 29 
 30 
 31 
 32 
 33 
Tew et al. Sympathetic nerves, thermal hyperemia and aging 
 
2 
 
ABSTRACT 34 
Sedentary aging results in a diminished rapid cutaneous vasodilator response to 35 
local heating. We investigated whether this diminished response was due to altered 36 
contributions of noradrenergic sympathetic nerves; assessing 1) the age-related 37 
decline and, 2) the effect of aerobic fitness. We measured skin blood flow (SkBF) 38 
(laser-Doppler flowmetry) in young (24±1 yr) and older (64±1 yr) endurance-trained 39 
and sedentary men (n=7 per group) at baseline and during 35 min of local skin 40 
heating to 42 °C at three forearm sites: 1) untreated; 2) bretylium tosylate (BT), 41 
preventing neurotransmitter release from noradrenergic sympathetic nerves; and 3) 42 
yohimbine and propranolol (YP), antagonising α- and β-adrenergic receptors. SkBF 43 
was converted to cutaneous vascular conductance (CVC) (SkBF/mean arterial 44 
pressure) and normalized to maximal CVC (%CVCmax) achieved by skin heating to 45 
44 °C. Pharmacological agents were administered using microdialysis. In the young 46 
trained, the rapid vasodilator response was reduced at the BT and YP sites (P<0.05); 47 
by contrast, in the young sedentary and older trained, YP had no effect (P>0.05) but 48 
treatment with BT did (P>0.05). Neither BT nor YP treatments affected the rapid 49 
vasodilator response in the older sedentary group (P>0.05). These data suggest that 50 
the age-related reduction in the rapid vasodilator response is due to an impairment 51 
of sympathetic-dependent mechanisms, which can be partly attenuated with habitual 52 
aerobic exercise. Rapid vasodilation involves noradrenergic neurotransmitters in 53 
young trained men, and non-adrenergic sympathetic cotransmitters (e.g., 54 
neuropeptide Y) in young sedentary and older trained men, possibly as a 55 
compensatory mechanism. Finally, in older sedentary men, the rapid vasodilation 56 
appears not to involve the sympathetic system. 57 
 58 
 59 
 60 
 61 
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 65 
 66 
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INTRODUCTION 68 
In humans, the cutaneous circulation performs a major role in the control of body 69 
temperature through the level of its perfusion. Under conditions of heat stress, skin 70 
blood flow (SkBF) can increase to greater than 6 L/min (30). In contrast, during 71 
exposure to extreme cold, SkBF can fall to almost zero (17).  In non-glabrous (hairy) 72 
skin, the SkBF response to thermal stimuli local to the site of measurement appears 73 
to be achieved via a sympathetic noradrenergic system releasing norepinephrine 74 
(NE) and the cotransmitter neuropeptide Y (NPY) and a non-adrenergic system that 75 
is heavily dependent on nitric oxide (NO) (12-13, 15). 76 
 77 
The skin hyperemic response to a non-painful, rapid heat stimulus is commonly used 78 
as a test of microvascular and endothelial function (6, 22) and involves at least two 79 
independent phases: an initial, rapid transitory rise, followed by a nadir, ultimately 80 
succeeded by a secondary rise and prolonged plateau (20, 23). The specific 81 
mechanisms underpinning these phases are complex and not completely understood. 82 
The rapid initial peak of the vasodilator response is thought to be primarily mediated 83 
by an axon reflex via activation of transient receptor potential vanilloid-1 (TRPV-1) 84 
receptors in C-fibre afferent nociceptive neurones (41). These sensory neurones 85 
might increase skin blood flow (SkBF) through the release of neuropeptides such as 86 
calcitonin gene-related peptide and/or substance P (4); however, these theories 87 
have yet to be directly tested. Additionally, NO has been shown to contribute 88 
modestly to the initial peak of the vasodilator response to rapid local heating (20, 23). 89 
The secondary rise and plateau in SkBF, in contrast, is heavily dependent on NO 90 
synthesis as inhibition of NO synthase (NOS) reduces this phase by approximately 91 
70% (20, 23). 92 
 93 
Recent work (12-13, 15) supports the somewhat counterintuitive concept that 94 
cutaneous noradrenergic sympathetic nerves are also involved in the cutaneous 95 
vasodilator response to local heating. Indeed, pre-synaptic blockade of 96 
neurotransmitter release from these nerves with bretylium tosylate (BT) abolishes 97 
the rapid vasodilator (initial) phase and greatly reduces the overall vasodilator 98 
response to slow local heating (+0.1°C·min-1) (13, 15). By performing separate post-99 
synaptic antagonism of α- and β-adrenergic receptors and of Y1 receptors, Hodges 100 
et al. (13) found evidence of roles for both NE and the cotransmitter NPY. Adrenergic 101 
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involvement in thermal hyperemia also has a rate dependency: the initial peak 102 
evoked by slow local heating (+0.1°C·min-1) is completely abolished by pre-treatment 103 
with BT; by contrast, the initial peak evoked by rapid local heating (+2°C·min-1) is 104 
only halved under conditions of sympathetic nerve blockade (12). 105 
 106 
The initial rapid peak and secondary plateau are diminished with sedentary aging (24, 107 
34). Whereas the diminished secondary plateau of older adults is largely explained 108 
by attenuated NO-mediated vasodilation (2, 24), the mechanisms underpinning the 109 
decline in the initial rapid vasodilation are less clear. Diminished functioning of local 110 
sensory nerves might be implicated, because sensory nerve function blockade using 111 
a topical local anesthetic cream abolishes the difference between young adults and 112 
older sedentary adults (33). In that study, the size of the initial peak and the 113 
contribution of sensory nerves to the initial peak were similar between older 114 
endurance-trained adults and younger adults, suggesting that regular aerobic 115 
exercise can preserve sensory nerve-mediated vasodilator function in older adults. 116 
Previous studies have demonstrated that aging is associated with decreases in skin 117 
sympathetic efferent outflow in response to heat exposure (10) and vasoconstrictor 118 
responsiveness to NE (36, 40). Therefore, the diminished initial peak of sedentary 119 
older adults might also involve a decreased contribution of noradrenergic 120 
sympathetic nerves. 121 
 122 
Hence, the primary aim of this study was to investigate the role of cutaneous 123 
noradrenergic sympathetic nerves in the age-related decline in the initial rapid 124 
vasodilator response to local heating. A secondary aim was to further investigate the 125 
effect of regular aerobic exercise (as reflected by a higher aerobic fitness) on the 126 
initial peak in both young and older adults, assessing whether the effects of habitual 127 
exercise on cutaneous vasodilation can be explained by altered contributions of 128 
sympathetic neurotransmitters. We hypothesized that the contribution of 129 
noradrenergic sympathetic nerves to the initial vasodilator response would be 130 
greater in the young and well-trained individuals compared to the older sedentary 131 
individuals. 132 
 133 
 134 
 135 
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MATERIALS AND METHODS 136 
Ethics approval 137 
This study was approved by the Ethics Committee of Sheffield Hallam University and 138 
conducted according to the principles of the Declaration of Helsinki. Written, 139 
informed consent was obtained before participants entered the study. 140 
 141 
Participants 142 
We recruited 28 men who were equally divided among four groups: young 143 
endurance-trained (24 ± 1 yr), young sedentary (25 ± 1 yr), older endurance-trained 144 
(64 ± 1 yr) and older sedentary (64 ± 1 yr). The trained participants were recruited 145 
from running and cycling clubs in and around Sheffield, UK. They had all performed 146 
vigorous endurance exercise for ≥3 times·week-1, ≥30 min·session-1 and ≥5 years. 147 
The sedentary participants reported undertaking no regular exercise. All participants 148 
were healthy, non-smokers, free from cardiovascular disease and diabetes, and 149 
were not taking any medications. The participants attended the testing facility on two 150 
separate occasions. For both sessions, they were asked to refrain from caffeine, 151 
alcohol, and exercise for 24 h prior to their attendance. The participants are the 152 
same as those described in a recently published article by our group (33). 153 
 154 
Visit 1: Assessment of cardiopulmonary fitness 155 
Participants completed a continuous, incremental cycling test to volitional exhaustion 156 
on an electronically-braked cycle ergometer (Excalibur Sport, Lode, The 157 
Netherlands). Pedalling frequency was self-selected within the range of 60 to 90 158 
rev·min-1. After a 2-min warm-up against no resistance (0 W), the intensity of 159 
exercise was increased by 20 to 30 W·min-1. Participants were encouraged to 160 
continue cycling to volitional exhaustion or until a plateau in oxygen consumption 161 
was observed. Heart rate was recorded continuously by electrocardiogram 162 
(Cardioperfect, Welch Allyn, USA). The volume of oxygen consumed during exercise 163 
was calculated from minute ventilation, measured using a pneumotach, and 164 
simultaneous breath-by-breath analysis of expired gas fractions (Ultima CardiO2, 165 
MedGraphics, USA). Gas analysers and flow probes were calibrated before each 166 
test. Oxygen consumption was expressed relative to body mass (mL·kg-1·min-1). 167 
Maximal oxygen consumption (V O2max) was calculated as the highest consecutive 168 
Tew et al. Sympathetic nerves, thermal hyperemia and aging 
 
6 
 
20-second period of gas exchange data in the last minute before volitional 169 
exhaustion, which generally occurred due to leg fatigue and/or breathlessness. 170 
 171 
Visit 2: Assessment of SkBF responses to local heating 172 
Instrumentation 173 
The microvascular assessments were performed in a temperature-controlled room 174 
(22 to 24°C) with participants resting supine and the experimental (left) arm 175 
positioned at heart level for the entire protocol. Blood pressure was measured 176 
automatically on the right arm every 2 min (Dinamap Dash 2500, GE Healthcare, 177 
USA).  178 
 179 
Two microdialysis fibers (Linear 30, CMA Microdialysis Ltd, Stockholm, Sweden) 180 
with a membrane length of 10 mm and a 6-kDa molecular mass cut-off were placed 181 
~5 cm apart in the dermal layer of skin on the ventral aspect of the left forearm. 182 
Before implantation, the skin was temporarily anesthetised by applying an ice pack 183 
for 5 min (11). A 21-gauge needle was introduced aseptically into the dermis along a 184 
length of ~2.5 cm before exiting. A microdialysis fiber was threaded through the 185 
lumen of the needle, before removing the needle to leave the fiber in place. All 186 
microdialysis fibers were placed in this manner. To allow for the effects of the 187 
insertion trauma to subside, we waited 1.5-2 h before beginning the protocol (13).  188 
 189 
To obtain an index of SkBF, cutaneous red blood cell flux was measured using laser 190 
Doppler flowmetry (Periflux 5000 System, Perimed AB, Järfälla, Sweden) at the two 191 
microdialysis sites, and at a third "no fiber" control site. Local heater discs (Model 192 
455, Perimed AB) were used to control local skin temperature and integrating laser 193 
Doppler probes (Model 413, Perimed AB) were placed in the centre of each local 194 
heating disc.  195 
 196 
Drugs 197 
Blockade of neurotransmitter release from sympathetic adrenergic nerves was 198 
achieved at one of the microdialysis sites by administering a 20 mM solution of BT 199 
(US Pharmacopeia, Rockville, MD, USA). Administration of BT causes a selective 200 
and localised blockade of neurotransmitter release from cutaneous sympathetic 201 
adrenergic nerves lasting several hours (19). 202 
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 203 
Blockade of the α- and β-adrenergic receptors was achieved by administering a 204 
combination of 5 mM yohimbine (Sigma Aldrich, St. Louis, MO, US) and 1 mM 205 
propranolol (Sigma Aldrich) to antagonise those receptors. Herein, these skin sites 206 
will be termed the YP sites. Yohimbine is traditionally regarded as an α2-adrenergic 207 
antagonist; however, this combination and concentration of adrenergic antagonists 208 
has previously been shown to be effective in inhibiting the cutaneous vascular 209 
responses to exogenous NE (18, 31), suggesting that all α- and β-adrenergic 210 
receptors are blocked. 211 
 212 
As for previous studies investigating the role of sympathetic-dependent mechanisms 213 
in cutaneous vasodilation, all drugs were infused at a rate of 4 μL·min-1 (12-13). 214 
 215 
Protocol 216 
Data collection began after the trauma resolution period. Baseline data were 217 
recorded for 5 min with the local heating disc temperature at 33 °C. The temperature 218 
of the discs was then increased at a rate of 1 °C every 10 s to 42 °C (34) and held 219 
constant at this temperature for 35 min (32). After this, local heating temperature was 220 
increased to 44 °C for 10 min to induce maximal SkBF (37). No participants 221 
experienced any pain or discomfort during the local heating protocol. 222 
 223 
Data collection and analysis 224 
SkBF data were divided by mean arterial pressure to calculate cutaneous vascular 225 
conductance (CVC). CVC data were expressed as raw values (au/mmHg) and as a 226 
percentage of maximal vasodilation recorded during local heating to 44 °C 227 
(%CVCmax). Because of the rapid and transient nature of the initial peak responses, 228 
stable 30-s periods of SkBF were used for analysis. For the secondary plateau and 229 
maximal SkBF phases, stable 2-min periods of SkBF were used for analysis.  230 
 231 
To assess the contribution of sympathetic adrenergic nerves to the initial peak in 232 
each group, we compared the SkBF responses between the control and drug sites. 233 
For example, similar responses between all three sites would suggest that NE and 234 
NPY do not contribute to the initial peak. If the initial peak is equally depressed at the 235 
BT and YP sites, this would indicate that NE contributes to the initial peak, whereas 236 
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NPY does not. Finally, if the initial peak is depressed at the BT site, but not the YP 237 
site, this would indicate that NPY contributes to the initial peak, whereas NE does 238 
not. 239 
 240 
Participant characteristics were compared among groups using a one-way 241 
independent ANOVA (SAS v9.1, SAS Institute, Cary, NC). The effects of age, 242 
training status, and pharmacological manipulations on hemodynamic measures 243 
were assessed using a three-way ANOVA. Where significant interaction effects were 244 
observed, Tukey's post hoc analyses were used to identify significant differences in 245 
the pairwise comparisons. Statistical significance was set at P<0.05 and all data are 246 
presented as means ± S.E.M. 247 
 248 
 249 
 250 
 251 
 252 
 253 
 254 
 255 
 256 
 257 
 258 
 259 
 260 
 261 
 262 
 263 
 264 
 265 
 266 
 267 
 268 
 269 
 270 
Tew et al. Sympathetic nerves, thermal hyperemia and aging 
 
9 
 
RESULTS 271 
Participant characteristics 272 
The characteristics of the participants have been reported previously (33). Briefly, 273 
the groups did not differ in body mass, stature, or resting systolic or diastolic blood 274 
pressure (P>0.05). All participants were normotensive and achieved V O2max 275 
according to standard criteria (16). The V O2max of the young trained (58 ± 3 mL·kg-276 
1·min-1) was higher (P<0.05) than that of the young sedentary (40 ± 2 mL·kg-1·min-1), 277 
older trained (44 ± 2 mL·kg-1·min-1), and older sedentary (28 ± 2 mL·kg-1·min-1). The 278 
V O2max of the older sedentary was lower than that of all other groups (P<0.05), and 279 
there was no difference between the young sedentary and older trained (P>0.05).  280 
 281 
CVC responses 282 
Local heating resulted in the characteristic biphasic SkBF response previously 283 
described (23), i.e., an initial rapid increase and peak at the onset of heating, a brief 284 
nadir, and then a slower rise and plateau. This pattern was seen in all four groups 285 
and at all skin sites. 286 
 287 
Normalized baseline 288 
Baseline CVC did not differ among groups at each skin site (P>0.05). For example, 289 
control-site baseline CVC for the young trained, young sedentary, older trained and 290 
older sedentary was 7 ± 1, 8 ± 1, 7 ± 1, and 8 ± 1 %CVCmax, respectively (P>0.05). 291 
Furthermore, baseline CVC did not differ among skin sites within any of the groups 292 
(P>0.05) (e.g. young sedentary control site: 8 ± 1, BT site: 9 ± 1, and YP site: 9 ± 293 
1 %CVCmax), indicating no effect of pharmacological treatment. 294 
 295 
Normalized initial peak 296 
Figure 1 shows the normalized initial peak data for all groups at the control, BT, and 297 
YP sites. At the control site, the initial peak of the young trained and older trained (82 298 
± 3 and 79 ± 3 %CVCmax, respectively) was higher (P<0.05) than that of the young 299 
sedentary and older sedentary (74 ± 3 and 66 ± 5 %CVCmax, respectively). The 300 
initial peak of the older sedentary was also lower than that of the young sedentary 301 
(P<0.05), and there was no difference between the young trained and older trained 302 
(P>0.05). The difference in the initial peak between trained and sedentary groups 303 
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was more pronounced in the older men compared to the young men (19 ± 4 vs. 11 ± 304 
2 %, respectively; P<0.05). 305 
 306 
The initial peak at the BT site was lower (P<0.05) than that at the control site in all 307 
groups except the older sedentary (control minus BT: young trained 10 ± 3, young 308 
sedentary 7 ± 2, older trained 9 ± 2, older sedentary 2 ± 1 %CVCmax) (Fig. 1). In 309 
addition, the initial peak at the BT site did not differ between the young trained, 310 
young sedentary, and older trained (P>0.05), whereas the responses of the older 311 
sedentary were lower than those of the young trained and older trained (P<0.05). 312 
 313 
In the young trained, the initial peak at the YP site was lower than that at the control 314 
site (control minus YP: 11 ± 3 %CVCmax; P<0.05); however, the initial peak was 315 
similar between the BT and YP sites (72 ± 6 and 72 ± 4 %CVCmax, respectively; 316 
P>0.05), suggesting that NE contributes to the initial peak in young trained adults, 317 
whereas NPY does not (Fig. 1). In the young sedentary and older trained, the initial 318 
peak at the YP site (75 ± 2 and 77 ± 3 %CVCmax, respectively) did not differ 319 
(P>0.05) to that at the control site (74 ± 3 and 79 ± 4 %CVCmax, respectively). 320 
Considering the reduced vasodilator response under conditions of BT but not YP in 321 
these groups, this suggests a role for NPY, but not NE, in the initial peak of these 322 
groups. As with BT treatment, YP did not effect the initial peak in the older sedentary 323 
(control minus YP: 0 ± 1 %CVCmax; P>0.05). 324 
 325 
Normalized plateau 326 
Figure 2 shows the normalized plateau data for all groups at the control, BT, and YP 327 
sites. The plateau at the control site did not differ among groups (P>0.05). The 328 
plateau at the BT site was lower (P<0.05) than that at the control site for the young 329 
trained (71 ± 1 vs. 91 ± 2 %CVCmax, respectively) and older trained (85 ± 3 vs. 93 ± 330 
2 %CVCmax, respectively). In contrast, the plateau was similar (P>0.05) between BT 331 
and control sites in the young sedentary (85 ± 5 vs. 90 ± 3 %CVCmax, respectively) 332 
and older sedentary (91 ± 3 vs. 94 ± 1 %CVCmax, respectively). The plateau at the 333 
YP site in the young trained and older trained (90 ± 2 and 92 ± 3 %CVCmax, 334 
respectively) did not differ to that at the control site (P>0.05). In these groups, BT but 335 
not YP reduced vasodilatation; this suggests a role for NPY, but not NE, in the 336 
plateau of these groups. As with BT treatment, YP did not affect (P>0.05) the plateau 337 
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in the young sedentary and older sedentary (88 ± 2 and 91 ± 2 %CVCmax, 338 
respectively). 339 
 340 
Raw CVC responses 341 
The findings for the raw (non-normalized) data (Table 1) are similar to those for the 342 
normalized data. There was no effect of group or treatment on baseline responses 343 
(P>0.05). The control-site initial peak was higher in the young trained compared to all 344 
other groups (P<0.05), whereas the response of the older sedentary was lower than 345 
all other groups (P<0.05). There was no difference between the young sedentary 346 
and older trained (P>0.05). The control-site plateau was higher in the young trained 347 
compared to all other groups (P<0.05), and there were no differences among the 348 
remaining three groups (P>0.05). Treatment with BT and YP reduced the initial peak 349 
and plateau in the young trained only (P<0.05), and these phases did not differ 350 
between groups at the BT and YP sites (P>0.05). Finally, in the young trained, the 351 
initial peak did not differ between BT and YP sites (P>0.05), whereas the plateau 352 
was lower at the BT site compared to the YP site (P<0.05). 353 
 354 
 355 
 356 
 357 
 358 
 359 
 360 
 361 
 362 
 363 
 364 
 365 
 366 
 367 
 368 
 369 
 370 
 371 
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DISCUSSION 372 
The main novel findings from this study are: i) the age-related decline in the rapid 373 
skin hyperemic response to localized heating is partially explained by a diminished 374 
contribution of noradrenergic sympathetic nerves; ii) the contribution of 375 
noradrenergic sympathetic nerves to the initial peak is greater in individuals who 376 
have a higher aerobic fitness; and, iii) the sympathetic neurotransmitters contributing 377 
to the initial peak vary between young trained, young sedentary and older trained 378 
adults. Our data suggest that NE contributes to the initial peak of the young trained, 379 
whereas NPY does not. Conversely, NPY seems to play a role in the initial peak of 380 
the young sedentary and older trained, whereas NE does not. In the older sedentary, 381 
there is a significant reduction in the initial peak and no involvement of noradrenergic 382 
sympathetic nerves.   383 
 384 
Effects of aging on the initial peak and potential mechanisms 385 
The observation that the rapid skin hyperemic response to local heating was higher 386 
in both young groups compared to the older sedentary group is consistent with 387 
previous findings (24, 33-34). It has been suggested that a smaller initial peak might 388 
be associated with a greater risk of local tissue damage in response to directly 389 
applied heat (24, 41). This seems logical since a rapid increase in SkBF will 390 
minimize the heat transferred to the underlying tissues; however, further research is 391 
needed to substantiate this suggestion, especially since the initial peak normally 392 
does not usually occur until 3 to 4 min after the initiation of skin heating. In addition, 393 
the age-related decline in the initial peak might be associated with impaired wound 394 
healing. Indeed, the magnitude of the initial peak reflects sensory nerve function 395 
(e.g., (33)), which is known to be an important contributory factor to wound healing 396 
capacity (29). 397 
 398 
Our current findings suggest that the age-related decline is partly due to a 399 
diminished contribution of noradrenergic sympathetic nerves. Indeed, sympathetic 400 
nerve blockade decreased the initial peak in the young, but not the older sedentary, 401 
such that the between-group difference in the initial peak was smaller at the BT site 402 
than that at the control site (Figure 1). This finding may be due to the generalized 403 
decline in skin sympathetic efferent activity that occurs with primary aging (10), 404 
although other factors such as a reduced release and post-junctional binding of 405 
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sympathetic transmitters cannot be excluded. To improve our understanding of this 406 
matter, further research is needed to clarify the mechanisms by which noradrenergic 407 
sympathetic nerves contribute to local heating-induced cutaneous vasodilation. 408 
Previous research suggests that noradrenergic sympathetic nerves may sensitize 409 
the vascular responsiveness to local skin heating, which would affect the initial rise 410 
(axon reflex) in blood flow. Indeed, Houghton et al. (15) reported that low-dose NE 411 
infusion decreased the temperature threshold of the axon reflex response to slow 412 
local heating, and Drummond and Lipnicki (7) observed that iontophoresis of NE 413 
caused an axon reflex response in immediately adjacent skin that was blocked by 414 
pre-treatment with a local anesthetic cream. There might also be an important 415 
interaction between NE and/or NPY and the production of NO via endothelial NOS (1, 416 
5, 38), which would probably contribute more to the plateau phase of the local 417 
heating response; however, this is yet to be directly tested.  418 
 419 
Importantly, the age-related decrement in the initial peak was not completely 420 
abolished by sympathetic nerve blockade, indicating that other factors are involved. 421 
One such factor might be a diminished functioning of heat-sensitive nociceptors, 422 
since sensory nerve function blockade has been shown to abolish the difference in 423 
the initial peak between young adults and older sedentary adults (33). Nitric oxide 424 
might also be implicated given that it contributes modestly to the initial peak (20, 23); 425 
however, a previous study showed that NOS inhibition did not abolish the difference 426 
in the initial peak between young and older adults (24). Nevertheless, NO might be 427 
involved via potential interactions with sensory nerves (41) and/or noradrenergic 428 
sympathetic nerves (13). Further research is needed to understand how 429 
noradrenergic sympathetic nerves, sensory nerves, and NO interact in the rapid 430 
vasodilator response to local heating and what their respective roles are in the age-431 
related decline in the initial peak. The current data would suggest that there is a 432 
considerable degree of redundancy among these systems, similar to what is known 433 
with reflex vasodilation in response to increases in core temperature (3).  434 
 435 
Effects of aerobic fitness on the initial peak and potential mechanisms 436 
The age-related decline in the initial peak was not present in the older trained, which 437 
is consistent with our previous findings (33-34) and indicates that participating in 438 
regular aerobic exercise preserves the capacity to rapidly increase SkBF in response 439 
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to skin heating into advanced age. Exercise training also appears to be associated 440 
with a higher initial peak in young adults; however, the impact of exercise training 441 
seems greater in older adults (Figure 1), perhaps because these individuals have 442 
greater potential for improvement relative to their younger counterparts. This is 443 
consistent with what is known about conduit artery and resistance vessel function; 444 
exercise training seems to enhance vascular function to a greater extent in those 445 
with depressed function at baseline (35).  446 
 447 
The difference in SkBF between the control and BT sites was lower in the sedentary 448 
groups, indicating that regular aerobic exercise can also increase the contribution of 449 
noradrenergic sympathetic nerves to the initial peak in both young and older adults. 450 
As for the aging data, the underpinning mechanisms of this finding are unclear. 451 
Nevertheless, the current study provides novel and important data on the effects of 452 
aging and aerobic fitness on local heating-induced cutaneous vasodilation and the 453 
contribution of sympathetic neurotransmitters to this response. Further research is 454 
needed to identify the acute and chronic effects of exercise on cutaneous 455 
neurovascular function, including noradrenergic sympathetic nerve function. 456 
 457 
Group-specific roles of NE and NPY in the initial peak 458 
Our findings also indicate that the sympathetic neurotransmitters contributing to the 459 
initial peak vary between young trained, young sedentary, and older trained adults. 460 
Indeed, NE seemed to play a role in the initial peak of the young trained and NPY did 461 
not. By contrast, NPY and not NE appeared to play a role in the initial peak of the 462 
young sedentary and older trained groups. Neither NE nor NPY appear to be 463 
involved in the relatively diminished initial peak of the older sedentary. Aging and 464 
sedentary behavior lead to an increase in sympathetic outflow and it is under 465 
stressful conditions that NPY appears to play a role in sympathetic function (26, 42). 466 
We propose our data indicate that a role for NPY only occurs as a compensatory 467 
mechanism. NE is the neurotransmitter usually used (young trained), but with a 468 
sedentary lifestyle (young untrained) or primary aging (older trained) it would appear 469 
that NPY is required to compensate for a loss of adrenergic function. Currently, we 470 
are unable to speculate as to whether this is due to pre- or post-synaptic alterations, 471 
i.e. whether these changes are due to alterations in transmitter synthesis and 472 
release or in receptor density or affinity. The combination of a sedentary lifestyle and 473 
Tew et al. Sympathetic nerves, thermal hyperemia and aging 
 
15 
 
aging appears to result in a complete loss of sympathetic involvement, such that the 474 
initial peak responses under control conditions for the older sedentary group were 475 
somewhat similar to the responses achieved at the BT-treated sites for the other 476 
three groups. Also note the absence of any change following treatment with BT or 477 
YP. 478 
 479 
Effects of age and aerobic fitness on the plateau and maximum CVC 480 
responses and the role of noradrenergic sympathetic nerves 481 
The secondary plateau of the SkBF response to local heating, did not differ between 482 
groups when the data were normalized to maximal CVC (Figure 2), which is in 483 
contrast to some of the previous studies that have investigated the impact of age and 484 
exercise training on local heating-induced SkBF responses (8-9, 14, 21, 24, 27-28, 485 
39), but not all (2, 25). However, this finding might simply reflect our approach of 486 
normalizing data to CVC values recorded during local heating at 44 °C. Although this 487 
method, which is used to account for the wide heterogeneity in capillary density 488 
across the forearm, is acceptable in healthy young adults and in mechanistically-489 
driven, carefully controlled studies (22), it might be inappropriate for comparing data 490 
between young and older adults (24-25), because of the age-associated decline in 491 
the maximal SkBF response to local heating (21). For example, the CVC responses 492 
during the plateau phase were similar between groups when expressed 493 
as %CVCmax, but lower in the older groups compared to the young trained when 494 
expressed as raw CVC (Table 1). Therefore, although participants from all groups 495 
reached a similar %CVCmax, lower maximal CVC values in aged skin would 496 
probably translate to a lower absolute SkBF for a given %CVCmax. Because of this 497 
issue, we chose to present data both as raw CVC and %CVCmax. Reassuringly, the 498 
interpretation of the initial peak data did not change greatly between these different 499 
methods. 500 
 501 
Our findings indicate that the contribution of cutaneous sympathetic nerves to the 502 
plateau phase of heat-induced vasodilation is dependent on the individual's aerobic 503 
fitness. Indeed, sympathetic nerve blockade using BT decreased the plateau in the 504 
young and older trained, but not in the young and older sedentary groups (Figure 2). 505 
Three other studies have demonstrated that cutaneous noradrenergic sympathetic 506 
nerves contribute to the plateau in young healthy adults (12-13, 15). The data of 507 
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these studies are not directly comparable with our own because two of the three 508 
studies used a slow heating protocol (+0.1 °C·min-1) (13, 15), and the fitness/training 509 
status of the participants was unclear throughout. Whereas both NE and NPY 510 
contribute to the plateau response to slow local heating (13, 15), it seems that the 511 
sympathetic-related contribution to rapid local heating (in the trained groups) 512 
involves NPY only. Further research is needed to help understand this difference 513 
and how exercise training alters the contribution of sympathetic neurotransmitters. 514 
 515 
A final curious observation that warrants discussion is that maximal raw CVC in the 516 
young trained group was significantly greater at the control sites compared with the 517 
BT and YP treated sites (Table 1). No differences were observed among the sites in 518 
the other three groups. This may be due to the fact that the BT and YP treated sites 519 
had microdialysis fibers present, while the control site did not; however, as this 520 
scenario did not occur in any of the other groups we feel this is unlikely. What this 521 
might indicate, is that, in young trained adults, either noradrenergic sympathetic 522 
nerves contribute to the maximal CVC response to local heating at 44 °C (similar to 523 
what we have observed for initial peak and plateau phase data) or that local heating 524 
to 44 °C was an insufficient stimulus to elicit a maximal vasodilator response. As we 525 
are unable to definitively state whether or not "true" maximum CVC was obtained at 526 
every skin site in the different groups, inspection of the raw CVC responses (Table 1) 527 
is particularly important in the interpretation of our results. Reassuringly, both 528 
methods of data presentation support our interpretation of the initial peak results. 529 
 530 
Experimental considerations 531 
It might be argued that our assessment of drug effects was clouded by the fact that 532 
we did not have a microdialysis fiber at the control site. Indeed, it has previously 533 
been demonstrated that fiber placement alone decreases the peak reflex cutaneous 534 
vasodilator response to whole body heating (11). However, that study also showed 535 
that this attenuation did not occur if ice was applied for 5 min before fiber placement. 536 
Since we used ice in this manner, any reported between-site differences are 537 
probably due to the action of the drugs and not the absence of a microdialysis fiber 538 
at the control site. Furthermore, our pilot tests (n=5) investigating this issue indicated 539 
that the SkBF response to rapid local heating is not affected by ice treatment + fiber 540 
placement (e.g., normalized initial peak: fiber 71 ± 7 %CVCmax vs. no-fiber 67 ± 541 
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7 %CVCmax; raw maximum: fiber 2.56 ± 0.22 au/mmHg vs. no-fiber 2.36 ± 0.12 542 
au/mmHg; P = 0.13 and P = 0.40, respectively). 543 
 544 
Another potential limitation is that we did not use a NPY-specific antagonist such as 545 
BIBP-3226 to assess the contribution of NPY to the thermal hyperemic response. 546 
Hodges et al. (13) previously assessed the contribution of NE and NPY to the 547 
cutaneous vasodilator response to slow local heating using a 4-site "Latin-square" 548 
design: (i) control, (ii) α- and β-adrenoceptor antagonism, (iii) Y1-receptor 549 
antagonism, and (iv) a combination of (ii) and (iii). We could not use this approach 550 
because we currently only have a 3-channel laser Doppler flowmeter. Nevertheless, 551 
with only 3 sites (control, neurotransmitter block, and α- and β-adrenoceptor 552 
antagonism), we were essentially able to obtain the effects of NE and, indirectly NPY. 553 
 554 
In summary, we present a comparison of cutaneous microvascular responses to 555 
localised heating between young and older endurance-trained and sedentary 556 
individuals, with specific focus on the initial vasodilator response and the contribution 557 
of noradrenergic sympathetic nerves to this phase. At untreated control sites, the 558 
initial vasodilator response to local heating was lower in the older sedentary 559 
compared to both young groups. The lower responses of the older sedentary 560 
appeared to be partly explained by diminished contribution of noradrenergic 561 
sympathetic nerves. Our findings also indicate that the sympathetic contribution to 562 
the initial peak can be preserved into advanced age by maintaining a high level of 563 
aerobic fitness and/or participating in regular aerobic exercise. Finally, the 564 
sympathetic neurotransmitters contributing to the initial peak vary between young 565 
trained, young sedentary and older trained men. Specifically, NE seems to play a 566 
role in the initial peak of young trained men, whereas NPY does not. Conversely, 567 
NPY seems to play a role in the initial peak of young sedentary and older trained 568 
men, whereas NE does not. Finally, in older sedentary men, the rapid vasodilation is 569 
greatly reduced with no involvement of the sympathetic system. 570 
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FIGURE LEGENDS 712 
Fig. 1: Initial vasodilation to local skin heating. Data are means + S.E.M. for each 713 
group and skin site. CT, control sites; BT, bretylium tosylate treated sites; YP, 714 
yohimbine and propranolol treated sites. Symbols indicate P<0.05 as follows: * vs. 715 
control site within group; † vs. young trained; ‡ vs. older trained; § vs. young untrained. 716 
 717 
Fig. 2: Normalized secondary plateau CVC responses to local heating. Data are 718 
means + S.E.M. for each group and skin site. CT, control sites; BT, bretylium tosylate 719 
treated sites; YP, yohimbine and propranolol treated sites. Symbols indicate P<0.05 720 
as follows: * vs. control site within group. 721 
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Table 1. Raw CVC data for each phase of the local heating protocol 
 Young 
trained 
Young 
sedentary 
Older  
trained 
Older 
sedentary 
Baseline  
CT 
BT 
YP 
 
0.23 ± 0.03 
0.19 ± 0.03 
0.24 ± 0.02  
 
0.22 ± 0.02 
0.23 ± 0.03 
0.26 ± 0.02 
 
0.25 ± 0.03 
0.20 ± 0.03 
0.27 ± 0.04 
 
0.20 ± 0.03 
0.25 ± 0.02 
0.26 ± 0.04 
Initial peak  
CT 
BT 
YP 
 
2.66 ± 0.13 
1.70 ± 0.28* 
1.77 ± 0.20*  
 
2.05 ± 0.13† 
2.01 ± 0.22 
1.89 ± 0.13 
 
2.02 ± 0.23† 
1.95 ± 0.34 
2.05 ± 0.25 
 
1.75 ± 0.12†‡§
1.82 ± 0.19 
1.67 ± 0.07 
Plateau  
CT 
BT 
YP 
 
2.95 ± 0.16 
1.77 ± 0.36* 
2.18 ± 0.15*$ 
 
2.48 ± 0.15† 
2.39 ± 0.36† 
2.48 ± 0.22† 
 
2.38 ± 0.25† 
2.35 ± 0.36† 
2.42 ± 0.24† 
 
2.50 ± 0.11† 
2.63 ± 0.32† 
2.46 ± 0.36† 
Maximum 
CT 
BT 
YP 
 
3.27 ± 0.18 
2.42 ± 0.24* 
2.44 ± 0.17* 
 
2.74 ± 0.23† 
2.73 ± 0.26 
2.80 ± 0.22 
 
2.55 ± 0.20† 
2.73 ± 0.28 
2.64 ± 0.24 
 
2.64 ± 0.25† 
2.87 ± 0.27 
2.65 ± 0.36 
Data are expressed as means ± S.E.M. CVC, cutaneous vascular conductance. 
*Different to the corresponding control (CT) site (P<0.05); $Different to the 
corresponding bretylium (BT) site (P<0.05); †Different to the young trained (P<0.05); 
‡Different to the young sedentary (P<0.05); §Different to the older sedentary (P<0.05). 
